Drug News—July 2024A review of new launches, new indications, new dosage forms and Health Canada advisories. POP QUIZ: Velsipity for ulcerative colitisCan you tell which of these statements is false? High-dose NSAID + PPI + colchicine? It’s probably pericarditis Pericarditis can be self-limiting and occur in younger persons with no previous cardiac history—and is thus likely underreported. Breast cancer drugs could fight prostate cancer The effectiveness of androgen-targeted treatments for prostate cancer tends to fade over time, so new strategies are urgently needed. JULY UPDATE: New indications for six drugs prescribers and pharmacists should know about Check out these new indications for six drugs as part of our July drug news roundup. NEW DRUG: Tecentriq SC for multiple cancer types Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Ondexxya for rapid reversal of anticoagulation Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Doptelet for severe and chronic thrombocytopenia Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Velsipity for ulcerative colitis Get the info you need on this new product, part of our drug news roundup for July. Methylphenidate ER chewable tablets now available for ADHD treatment Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12. First Previous 13 14 15 16 17 Next Last
